1.07
Lucid Diagnostics Inc Aktie (LUCD) Neueste Nachrichten
GenomeWeb Names Lucid Diagnostics (Nasdaq: LUCD) 2025 Best Places to Work Honoree - Stock Titan
Ranking Lucid Diagnostics Inc. among high performing stocks via tools2025 Top Decliners & AI Powered Trade Plan Recommendations - newser.com
Lucid Diagnostics stock maintains Overweight rating at Cantor Fitzgerald By Investing.com - Investing.com Canada
Developing predictive dashboards with Lucid Diagnostics Inc. dataBear Alert & Fast Gain Swing Alerts - newser.com
Lucid Diagnostics stock maintains Overweight rating at Cantor Fitzgerald - Investing.com
Live market analysis of Lucid Diagnostics Inc.Weekly Market Report & Long Hold Capital Preservation Tips - newser.com
Why retail investors favor Lucid Diagnostics Inc. stockAnalyst Downgrade & Stock Portfolio Risk Control - newser.com
Is Lucid Diagnostics Inc. stock oversold or undervaluedMarket Growth Report & Pattern Based Trade Signal System - newser.com
Measuring Lucid Diagnostics Inc.’s beta against major indices - newser.com
Lucid Diagnostics’ Earnings Call: Strategic Wins Amid Challenges - MSN
Combining machine learning predictions for Lucid Diagnostics Inc.2025 Major Catalysts & Daily Volume Surge Trade Alerts - newser.com
Why Lucid Diagnostics Inc. stock is considered a top pickJuly 2025 Momentum & Community Consensus Picks - newser.com
Is Lucid Diagnostics Inc. meeting your algorithmic filter criteriaEarnings Performance Report & Weekly Momentum Stock Picks - newser.com
Earnings call transcript: Lucid Diagnostics Q3 2025 reports revenue growth and strategic advancements - Investing.com Nigeria
Lucid Diagnostics Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:LUCD) 2025-11-14 - Seeking Alpha
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - Eastern Progress
How supply chain issues affect Lucid Diagnostics Inc. stockJuly 2025 Setups & Daily Profit Focused Screening - Fundação Cultural do Pará
Lucid Diagnostics Inc. (LUCD) Reports Q3 Loss, Lags Revenue Estimates - MSN
Lucid Diagnostics Gains Medicare Support for EsoGuard - MSN
Is Lucid Diagnostics Inc. stock ready for a breakoutJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - newser.com
Needham reiterates Buy rating on Lucid Diagnostics stock amid EsoGuard growth By Investing.com - Investing.com South Africa
PAVmed Inc (PAVM) Q3 2025 Earnings Call Highlights: Strategic Pa - GuruFocus
PAVmed Inc (PAVM) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Financial ... - Yahoo Finance
Lucid Diagnostics to Participate in the Canaccord Genuity MedTec - GuruFocus
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2025 Earnings Call Transcript - Insider Monkey
Earnings Call Summary | Lucid Diagnostics(LUCD.US) Q3 2025 Earnings Conference - 富途牛牛
PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results - MarketScreener
Needham reiterates Buy rating on Lucid Diagnostics stock amid EsoGuard growth - Investing.com Nigeria
Needham Reiterates Lucid Diagnostics (LUCD) Buy Recommendation - Nasdaq
Lucid Diagnostics earnings beat, revenue fell short of estimates By Investing.com - Investing.com Australia
Lucid Diagnostics Inc (LUCD) Q3 2025 Earnings Call Highlights: Strategic Growth Plans Amidst ... By GuruFocus - Investing.com Canada
Lucid Diagnostics Reports Q3 2025 Financial Results - TipRanks
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):